<DOC>
	<DOCNO>NCT00214617</DOCNO>
	<brief_summary>The objective research understand Crestor effectively reduce level bad cholesterol , LDL , blood . It hypothesize low dose , Crestor facilitate rate removal LDL blood . At high dose , increase potency Crestor explain reduction production LDL liver .</brief_summary>
	<brief_title>Effect Crestor Lipoprotein Metabolism Humans</brief_title>
	<detailed_description>Crestor demonstrate effective reduce plasma LDL 20 60 % dose dependent fashion . While primary mechanism action class agent increase expression LDL receptor result accelerated clearance LDL , increase potency Crestor comparison statin may suggest mechanism . We propose study rate incorporation deuterated labeled leucine VLDL apoB LDL apoB determine effect two dos Crestor ( 5 mg/day 40 mg/day ) production clearance apoB . Participants admit General Clinical Research Center three occasion ( 4 day , 3 night per admission ) metabolic study . This open-label study design reflect usual care first admission take place participant lipid-lowering therapy . The second admission occur minimum 6 week low dose ( 5mg/day ) . The dose increase 40 mg/day time discharge third admission occur minimum 6 week high dose . A secondary objective study examine rate production clearance apoA-I , major protein HDL , 2 dos Crestor . In addition reduction LDL , Crestor also report result characteristic dose-dependent increase HDL . The mechanism increase understood .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>. TG 200 400 mg/dL LDLc 160 250 mg/dL HDLc 30 50 mg/dL men 4065 mg/dL woman Lp ( ) less 30 mg/dL Age 50 75 year current lipidlowering therapy , primary hypertriglyceridemia ( TG &gt; 400 mg/dL ) , High HDL ( HDL &gt; 70 ) , high Lp ( ) , great 30 mg/dL presence betaVLDL agarose electrophoresis , current use immunosuppressive agent , hormone replacement therapy woman history cancer , active liver disease hepatic dysfunction ( AST ALT 1.5 x ULN ( Upper Limit Normal ) , excessive consumption alcohol , recent history drug abuse .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>hypercholesterolemia</keyword>
	<keyword>HMG CoA Reductase Inhibtors</keyword>
	<keyword>tracer kinetics</keyword>
	<keyword>Apolipoproteins</keyword>
</DOC>